id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2010-E-0039-0006,FDA,FDA-2010-E-0039,Determination of Regulatory Review Period for Purposes of Patent Extension: MULTAQ,Notice,N-Notice,2010-12-10T05:00:00Z,2010,12,2010-12-10T05:00:00Z,,2010-12-10T16:20:27Z,2010-31064,0,0,0900006480bb389f
FDA-2010-E-0039-0005,FDA,FDA-2010-E-0039,FDA/CDER to US Patent and Trademark Office - Letter,Other,LET-Letter,2010-10-27T04:00:00Z,2010,10,2010-10-27T04:00:00Z,,2010-10-27T15:05:39Z,,0,0,0900006480b789a2
FDA-2010-E-0039-0004,FDA,FDA-2010-E-0039,U.S. Patent & Trademark Office to FDA/CDER - Letter,Other,LET-Letter,2010-06-22T04:00:00Z,2010,6,2010-06-22T04:00:00Z,,2013-08-11T04:40:32Z,,0,0,0900006480b07d1b
FDA-2010-E-0039-0003,FDA,FDA-2010-E-0039,FDA/CDER to US Patent and Trademark Office - Letter,Other,LET-Letter,2010-03-04T05:00:00Z,2010,3,2010-03-04T05:00:00Z,,2013-07-27T23:10:40Z,,0,0,0900006480ab4531
FDA-2010-E-0039-0002,FDA,FDA-2010-E-0039,sanofi-aventis U.S. Inc. - Patent Term Extension  Application,Other,APP-Application,2010-03-04T05:00:00Z,2010,3,2010-03-04T05:00:00Z,,2013-07-27T23:04:35Z,,0,0,0900006480a7e3f7
FDA-2010-E-0039-0001,FDA,FDA-2010-E-0039,U.S. Patent & Trademark Office to FDA/CDER - Letter,Other,LET-Letter,2010-03-04T05:00:00Z,2010,3,2010-03-04T05:00:00Z,,2013-07-27T23:04:34Z,,0,0,0900006480a7e3f5